JPX · 4596.T
Kubota Pharmaceutical Holdings Co., Ltd.
¥57-¥1 (-1.72%)
Kubota Pharmaceutical Holdings Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 83.71% below the high.
Loading market information…
JPX · 9776.T · JPY
Stock price, dividends, earnings
Quote as of Feb 13, 2026, 05:58 AM UTC. Cached market data; not a live quote.
One-year closing-price history · JPY. Historical prices are not a forecast.
Sapporo Clinical Laboratory Inc.’s quoted price sits in the lower half of its reported 52-week range, 100.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Sapporo Clinical Laboratory Inc.’s forward annual dividend is ¥23 per share, paid annual. The forward yield is 1.18% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Sapporo Clinical Laboratory Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Established in Sapporo, Japan in 1965, Sapporo Clinical Laboratory Inc. operates a network of dispensing pharmacies across the country. The company provides an extensive array of diagnostic services, including clinical, pathological, and Holter examinations. Its services also extend to environmental health, offering food hygiene assessments that cover processed products, facility cleanliness, and food handler practices, as well as radiation safety management. Furthermore, Sapporo Clinical Laboratory Inc. develops, markets, and maintains specialized software, such as SCAN clinical testing systems. It also delivers support for establishing new clinics and offers the HiWeb21 platform for accessing inspection results. Additionally, the company provides ongoing sales and maintenance for a variety of clinical testing software solutions.
Latest available per-share figures in JPY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 02:18 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
¥57-¥1 (-1.72%)
Kubota Pharmaceutical Holdings Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 83.71% below the high.
¥735+¥9 (+1.24%)
internet infinity Inc.’s quoted price sits in the lower half of its reported 52-week range, 18.96% below the high.
¥215+¥1 (+0.47%)
Trans Genic Inc.’s quoted price sits in the lower half of its reported 52-week range, 55.85% below the high.
¥502-¥3 (-0.59%)
Sincere Co. Ltd.’s quoted price sits in the upper half of its reported 52-week range, 9.71% below the high.
¥591+¥4 (+0.68%)
Human Metabolome Technologies, Inc.’s quoted price sits in the lower half of its reported 52-week range, 22.85% below the high.
¥1,308+¥8 (+0.62%)
FB Care Service Co.,Ltd.’s quoted price sits in the upper half of its reported 52-week range, 4.53% below the high.
¥1,123-¥2 (-0.18%)
Miahelsa Holdings Corporation’s quoted price sits in the lower half of its reported 52-week range, 6.42% below the high.
¥506-¥11 (-2.13%)
MRT Inc.’s quoted price sits in the lower half of its reported 52-week range, 27.19% below the high.
